nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—Cisplatin—bone cancer	0.355	1	CbGbCtD
Ramipril—Upper respiratory tract infection—Epirubicin—bone cancer	0.00125	0.00193	CcSEcCtD
Ramipril—Stomatitis—Methotrexate—bone cancer	0.00125	0.00193	CcSEcCtD
Ramipril—Conjunctivitis—Methotrexate—bone cancer	0.00124	0.00193	CcSEcCtD
Ramipril—Influenza—Doxorubicin—bone cancer	0.00124	0.00192	CcSEcCtD
Ramipril—Asthma—Doxorubicin—bone cancer	0.00124	0.00192	CcSEcCtD
Ramipril—Dysphagia—Doxorubicin—bone cancer	0.00124	0.00192	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—bone cancer	0.00123	0.0019	CcSEcCtD
Ramipril—Sweating—Methotrexate—bone cancer	0.00123	0.0019	CcSEcCtD
Ramipril—Photosensitivity reaction—Epirubicin—bone cancer	0.00122	0.0019	CcSEcCtD
Ramipril—Feeling abnormal—Cisplatin—bone cancer	0.00122	0.0019	CcSEcCtD
Ramipril—Weight increased—Epirubicin—bone cancer	0.00122	0.00189	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—bone cancer	0.00122	0.00189	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—bone cancer	0.00121	0.00187	CcSEcCtD
Ramipril—Hepatobiliary disease—Methotrexate—bone cancer	0.00121	0.00187	CcSEcCtD
Ramipril—Epistaxis—Methotrexate—bone cancer	0.00121	0.00187	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—bone cancer	0.00119	0.00185	CcSEcCtD
Ramipril—Agranulocytosis—Methotrexate—bone cancer	0.00119	0.00185	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00119	0.00184	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—bone cancer	0.00118	0.00183	CcSEcCtD
Ramipril—Renal failure—Epirubicin—bone cancer	0.00118	0.00182	CcSEcCtD
Ramipril—Body temperature increased—Cisplatin—bone cancer	0.00117	0.00182	CcSEcCtD
Ramipril—Neuropathy peripheral—Epirubicin—bone cancer	0.00117	0.00182	CcSEcCtD
Ramipril—Stomatitis—Epirubicin—bone cancer	0.00117	0.00181	CcSEcCtD
Ramipril—Jaundice—Epirubicin—bone cancer	0.00117	0.00181	CcSEcCtD
Ramipril—Urinary tract infection—Epirubicin—bone cancer	0.00116	0.0018	CcSEcCtD
Ramipril—Conjunctivitis—Epirubicin—bone cancer	0.00116	0.0018	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—bone cancer	0.00116	0.0018	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00115	0.00179	CcSEcCtD
Ramipril—Hepatitis—Methotrexate—bone cancer	0.00115	0.00178	CcSEcCtD
Ramipril—Sweating—Epirubicin—bone cancer	0.00115	0.00178	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—bone cancer	0.00113	0.00176	CcSEcCtD
Ramipril—Hepatobiliary disease—Epirubicin—bone cancer	0.00113	0.00175	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—bone cancer	0.00113	0.00175	CcSEcCtD
Ramipril—Epistaxis—Epirubicin—bone cancer	0.00113	0.00175	CcSEcCtD
Ramipril—Sinusitis—Epirubicin—bone cancer	0.00112	0.00174	CcSEcCtD
Ramipril—Agranulocytosis—Epirubicin—bone cancer	0.00112	0.00173	CcSEcCtD
Ramipril—Visual impairment—Methotrexate—bone cancer	0.00111	0.00171	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.0011	0.0017	CcSEcCtD
Ramipril—Hypersensitivity—Cisplatin—bone cancer	0.00109	0.0017	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—bone cancer	0.00109	0.00169	CcSEcCtD
Ramipril—Erythema multiforme—Methotrexate—bone cancer	0.00109	0.00168	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—bone cancer	0.00109	0.00168	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—bone cancer	0.00108	0.00167	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—bone cancer	0.00108	0.00167	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—bone cancer	0.00108	0.00167	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—bone cancer	0.00108	0.00167	CcSEcCtD
Ramipril—Hepatitis—Epirubicin—bone cancer	0.00107	0.00166	CcSEcCtD
Ramipril—Tinnitus—Methotrexate—bone cancer	0.00107	0.00166	CcSEcCtD
Ramipril—Asthenia—Cisplatin—bone cancer	0.00107	0.00165	CcSEcCtD
Ramipril—Sweating—Doxorubicin—bone cancer	0.00106	0.00164	CcSEcCtD
Ramipril—Oedema peripheral—Epirubicin—bone cancer	0.00106	0.00164	CcSEcCtD
Ramipril—Connective tissue disorder—Epirubicin—bone cancer	0.00106	0.00164	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—bone cancer	0.00105	0.00162	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—bone cancer	0.00104	0.00162	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—bone cancer	0.00104	0.00161	CcSEcCtD
Ramipril—Immune system disorder—Methotrexate—bone cancer	0.00104	0.00161	CcSEcCtD
Ramipril—Visual impairment—Epirubicin—bone cancer	0.00104	0.0016	CcSEcCtD
Ramipril—Mediastinal disorder—Methotrexate—bone cancer	0.00103	0.0016	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—bone cancer	0.00103	0.0016	CcSEcCtD
Ramipril—Diarrhoea—Cisplatin—bone cancer	0.00102	0.00158	CcSEcCtD
Ramipril—Erythema multiforme—Epirubicin—bone cancer	0.00102	0.00157	CcSEcCtD
Ramipril—Alopecia—Methotrexate—bone cancer	0.00101	0.00157	CcSEcCtD
Ramipril—Mental disorder—Methotrexate—bone cancer	0.00101	0.00156	CcSEcCtD
Ramipril—Tinnitus—Epirubicin—bone cancer	0.001	0.00155	CcSEcCtD
Ramipril—Malnutrition—Methotrexate—bone cancer	0.000999	0.00155	CcSEcCtD
Ramipril—Erythema—Methotrexate—bone cancer	0.000999	0.00155	CcSEcCtD
Ramipril—Flushing—Epirubicin—bone cancer	0.000997	0.00154	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—bone cancer	0.000994	0.00154	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—bone cancer	0.000979	0.00152	CcSEcCtD
Ramipril—Dysgeusia—Methotrexate—bone cancer	0.000978	0.00152	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—bone cancer	0.000977	0.00151	CcSEcCtD
Ramipril—Immune system disorder—Epirubicin—bone cancer	0.00097	0.0015	CcSEcCtD
Ramipril—Mediastinal disorder—Epirubicin—bone cancer	0.000968	0.0015	CcSEcCtD
Ramipril—Arrhythmia—Epirubicin—bone cancer	0.000959	0.00149	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—bone cancer	0.000958	0.00148	CcSEcCtD
Ramipril—Alopecia—Epirubicin—bone cancer	0.000949	0.00147	CcSEcCtD
Ramipril—Vomiting—Cisplatin—bone cancer	0.000945	0.00146	CcSEcCtD
Ramipril—Mental disorder—Epirubicin—bone cancer	0.000941	0.00146	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—bone cancer	0.00094	0.00146	CcSEcCtD
Ramipril—Rash—Cisplatin—bone cancer	0.000937	0.00145	CcSEcCtD
Ramipril—Dermatitis—Cisplatin—bone cancer	0.000936	0.00145	CcSEcCtD
Ramipril—Malnutrition—Epirubicin—bone cancer	0.000935	0.00145	CcSEcCtD
Ramipril—Erythema—Epirubicin—bone cancer	0.000935	0.00145	CcSEcCtD
Ramipril—Ill-defined disorder—Methotrexate—bone cancer	0.000927	0.00144	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—bone cancer	0.000927	0.00144	CcSEcCtD
Ramipril—Flushing—Doxorubicin—bone cancer	0.000922	0.00143	CcSEcCtD
Ramipril—Tension—Epirubicin—bone cancer	0.000917	0.00142	CcSEcCtD
Ramipril—Dysgeusia—Epirubicin—bone cancer	0.000916	0.00142	CcSEcCtD
Ramipril—Nervousness—Epirubicin—bone cancer	0.000908	0.00141	CcSEcCtD
Ramipril—Malaise—Methotrexate—bone cancer	0.000901	0.0014	CcSEcCtD
Ramipril—Muscle spasms—Epirubicin—bone cancer	0.000899	0.00139	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—bone cancer	0.000898	0.00139	CcSEcCtD
Ramipril—Vertigo—Methotrexate—bone cancer	0.000898	0.00139	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—bone cancer	0.000896	0.00139	CcSEcCtD
Ramipril—Leukopenia—Methotrexate—bone cancer	0.000894	0.00139	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—bone cancer	0.000888	0.00138	CcSEcCtD
Ramipril—Nausea—Cisplatin—bone cancer	0.000883	0.00137	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—bone cancer	0.000878	0.00136	CcSEcCtD
Ramipril—Cough—Methotrexate—bone cancer	0.000872	0.00135	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—bone cancer	0.000871	0.00135	CcSEcCtD
Ramipril—Ill-defined disorder—Epirubicin—bone cancer	0.000868	0.00134	CcSEcCtD
Ramipril—Convulsion—Methotrexate—bone cancer	0.000866	0.00134	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—bone cancer	0.000865	0.00134	CcSEcCtD
Ramipril—Erythema—Doxorubicin—bone cancer	0.000865	0.00134	CcSEcCtD
Ramipril—Agitation—Epirubicin—bone cancer	0.000859	0.00133	CcSEcCtD
Ramipril—Arthralgia—Methotrexate—bone cancer	0.000851	0.00132	CcSEcCtD
Ramipril—Myalgia—Methotrexate—bone cancer	0.000851	0.00132	CcSEcCtD
Ramipril—Chest pain—Methotrexate—bone cancer	0.000851	0.00132	CcSEcCtD
Ramipril—Tension—Doxorubicin—bone cancer	0.000849	0.00132	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—bone cancer	0.000847	0.00131	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000845	0.00131	CcSEcCtD
Ramipril—Malaise—Epirubicin—bone cancer	0.000843	0.00131	CcSEcCtD
Ramipril—Discomfort—Methotrexate—bone cancer	0.00084	0.0013	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—bone cancer	0.00084	0.0013	CcSEcCtD
Ramipril—Vertigo—Epirubicin—bone cancer	0.00084	0.0013	CcSEcCtD
Ramipril—Syncope—Epirubicin—bone cancer	0.000838	0.0013	CcSEcCtD
Ramipril—Leukopenia—Epirubicin—bone cancer	0.000837	0.0013	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—bone cancer	0.000832	0.00129	CcSEcCtD
Ramipril—Palpitations—Epirubicin—bone cancer	0.000826	0.00128	CcSEcCtD
Ramipril—Confusional state—Methotrexate—bone cancer	0.000822	0.00127	CcSEcCtD
Ramipril—Loss of consciousness—Epirubicin—bone cancer	0.000822	0.00127	CcSEcCtD
Ramipril—Cough—Epirubicin—bone cancer	0.000816	0.00126	CcSEcCtD
Ramipril—Anaphylactic shock—Methotrexate—bone cancer	0.000815	0.00126	CcSEcCtD
Ramipril—Convulsion—Epirubicin—bone cancer	0.00081	0.00126	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—bone cancer	0.000803	0.00124	CcSEcCtD
Ramipril—Nervous system disorder—Methotrexate—bone cancer	0.0008	0.00124	CcSEcCtD
Ramipril—Thrombocytopenia—Methotrexate—bone cancer	0.000798	0.00124	CcSEcCtD
Ramipril—Arthralgia—Epirubicin—bone cancer	0.000796	0.00123	CcSEcCtD
Ramipril—Chest pain—Epirubicin—bone cancer	0.000796	0.00123	CcSEcCtD
Ramipril—Myalgia—Epirubicin—bone cancer	0.000796	0.00123	CcSEcCtD
Ramipril—Agitation—Doxorubicin—bone cancer	0.000795	0.00123	CcSEcCtD
Ramipril—Anxiety—Epirubicin—bone cancer	0.000793	0.00123	CcSEcCtD
Ramipril—Skin disorder—Methotrexate—bone cancer	0.000792	0.00123	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000791	0.00122	CcSEcCtD
Ramipril—Hyperhidrosis—Methotrexate—bone cancer	0.000788	0.00122	CcSEcCtD
Ramipril—Discomfort—Epirubicin—bone cancer	0.000786	0.00122	CcSEcCtD
Ramipril—Malaise—Doxorubicin—bone cancer	0.00078	0.00121	CcSEcCtD
Ramipril—Dry mouth—Epirubicin—bone cancer	0.000778	0.00121	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—bone cancer	0.000777	0.0012	CcSEcCtD
Ramipril—Anorexia—Methotrexate—bone cancer	0.000777	0.0012	CcSEcCtD
Ramipril—Syncope—Doxorubicin—bone cancer	0.000776	0.0012	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—bone cancer	0.000774	0.0012	CcSEcCtD
Ramipril—Confusional state—Epirubicin—bone cancer	0.000769	0.00119	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—bone cancer	0.000765	0.00118	CcSEcCtD
Ramipril—Anaphylactic shock—Epirubicin—bone cancer	0.000763	0.00118	CcSEcCtD
Ramipril—Oedema—Epirubicin—bone cancer	0.000763	0.00118	CcSEcCtD
Ramipril—Hypotension—Methotrexate—bone cancer	0.000762	0.00118	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—bone cancer	0.00076	0.00118	CcSEcCtD
Ramipril—Cough—Doxorubicin—bone cancer	0.000755	0.00117	CcSEcCtD
Ramipril—Shock—Epirubicin—bone cancer	0.000751	0.00116	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—bone cancer	0.00075	0.00116	CcSEcCtD
Ramipril—Nervous system disorder—Epirubicin—bone cancer	0.000748	0.00116	CcSEcCtD
Ramipril—Thrombocytopenia—Epirubicin—bone cancer	0.000747	0.00116	CcSEcCtD
Ramipril—Tachycardia—Epirubicin—bone cancer	0.000745	0.00115	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000743	0.00115	CcSEcCtD
Ramipril—Skin disorder—Epirubicin—bone cancer	0.000741	0.00115	CcSEcCtD
Ramipril—Hyperhidrosis—Epirubicin—bone cancer	0.000738	0.00114	CcSEcCtD
Ramipril—Insomnia—Methotrexate—bone cancer	0.000737	0.00114	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—bone cancer	0.000737	0.00114	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—bone cancer	0.000737	0.00114	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—bone cancer	0.000737	0.00114	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—bone cancer	0.000734	0.00114	CcSEcCtD
Ramipril—Paraesthesia—Methotrexate—bone cancer	0.000732	0.00113	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000731	0.00113	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—bone cancer	0.000728	0.00113	CcSEcCtD
Ramipril—Anorexia—Epirubicin—bone cancer	0.000727	0.00113	CcSEcCtD
Ramipril—Dyspnoea—Methotrexate—bone cancer	0.000727	0.00113	CcSEcCtD
Ramipril—Somnolence—Methotrexate—bone cancer	0.000725	0.00112	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—bone cancer	0.00072	0.00112	CcSEcCtD
Ramipril—Dyspepsia—Methotrexate—bone cancer	0.000718	0.00111	CcSEcCtD
Ramipril—Hypotension—Epirubicin—bone cancer	0.000713	0.0011	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—bone cancer	0.000712	0.0011	CcSEcCtD
Ramipril—Decreased appetite—Methotrexate—bone cancer	0.000709	0.0011	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—bone cancer	0.000706	0.00109	CcSEcCtD
Ramipril—Oedema—Doxorubicin—bone cancer	0.000706	0.00109	CcSEcCtD
Ramipril—Gastrointestinal disorder—Methotrexate—bone cancer	0.000704	0.00109	CcSEcCtD
Ramipril—Fatigue—Methotrexate—bone cancer	0.000703	0.00109	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000695	0.00108	CcSEcCtD
Ramipril—Shock—Doxorubicin—bone cancer	0.000695	0.00108	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—bone cancer	0.000692	0.00107	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—bone cancer	0.000691	0.00107	CcSEcCtD
Ramipril—Insomnia—Epirubicin—bone cancer	0.00069	0.00107	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—bone cancer	0.000689	0.00107	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—bone cancer	0.000686	0.00106	CcSEcCtD
Ramipril—Paraesthesia—Epirubicin—bone cancer	0.000685	0.00106	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—bone cancer	0.000683	0.00106	CcSEcCtD
Ramipril—Dyspnoea—Epirubicin—bone cancer	0.00068	0.00105	CcSEcCtD
Ramipril—Somnolence—Epirubicin—bone cancer	0.000678	0.00105	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—bone cancer	0.000673	0.00104	CcSEcCtD
Ramipril—Feeling abnormal—Methotrexate—bone cancer	0.000672	0.00104	CcSEcCtD
Ramipril—Dyspepsia—Epirubicin—bone cancer	0.000672	0.00104	CcSEcCtD
Ramipril—Gastrointestinal pain—Methotrexate—bone cancer	0.000667	0.00103	CcSEcCtD
Ramipril—Decreased appetite—Epirubicin—bone cancer	0.000663	0.00103	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—bone cancer	0.00066	0.00102	CcSEcCtD
Ramipril—Gastrointestinal disorder—Epirubicin—bone cancer	0.000659	0.00102	CcSEcCtD
Ramipril—Fatigue—Epirubicin—bone cancer	0.000658	0.00102	CcSEcCtD
Ramipril—Constipation—Epirubicin—bone cancer	0.000653	0.00101	CcSEcCtD
Ramipril—Urticaria—Methotrexate—bone cancer	0.000648	0.001	CcSEcCtD
Ramipril—Abdominal pain—Methotrexate—bone cancer	0.000645	0.000999	CcSEcCtD
Ramipril—Body temperature increased—Methotrexate—bone cancer	0.000645	0.000999	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000643	0.000997	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—bone cancer	0.000639	0.000989	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—bone cancer	0.000634	0.000982	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—bone cancer	0.000629	0.000975	CcSEcCtD
Ramipril—Feeling abnormal—Epirubicin—bone cancer	0.000629	0.000974	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—bone cancer	0.000628	0.000973	CcSEcCtD
Ramipril—Gastrointestinal pain—Epirubicin—bone cancer	0.000624	0.000967	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—bone cancer	0.000622	0.000963	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—bone cancer	0.000614	0.000951	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00061	0.000944	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—bone cancer	0.000609	0.000943	CcSEcCtD
Ramipril—Urticaria—Epirubicin—bone cancer	0.000606	0.000939	CcSEcCtD
Ramipril—Constipation—Doxorubicin—bone cancer	0.000604	0.000935	CcSEcCtD
Ramipril—Body temperature increased—Epirubicin—bone cancer	0.000603	0.000935	CcSEcCtD
Ramipril—Abdominal pain—Epirubicin—bone cancer	0.000603	0.000935	CcSEcCtD
Ramipril—Hypersensitivity—Methotrexate—bone cancer	0.000601	0.000931	CcSEcCtD
Ramipril—Asthenia—Methotrexate—bone cancer	0.000585	0.000906	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—bone cancer	0.000582	0.000901	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—bone cancer	0.000577	0.000895	CcSEcCtD
Ramipril—Pruritus—Methotrexate—bone cancer	0.000577	0.000894	CcSEcCtD
Ramipril—Hypersensitivity—Epirubicin—bone cancer	0.000562	0.000871	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—bone cancer	0.000561	0.000869	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—bone cancer	0.000558	0.000865	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—bone cancer	0.000558	0.000865	CcSEcCtD
Ramipril—Diarrhoea—Methotrexate—bone cancer	0.000558	0.000864	CcSEcCtD
Ramipril—Asthenia—Epirubicin—bone cancer	0.000547	0.000848	CcSEcCtD
Ramipril—Pruritus—Epirubicin—bone cancer	0.00054	0.000836	CcSEcCtD
Ramipril—Dizziness—Methotrexate—bone cancer	0.000539	0.000835	CcSEcCtD
Ramipril—Diarrhoea—Epirubicin—bone cancer	0.000522	0.000809	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—bone cancer	0.00052	0.000806	CcSEcCtD
Ramipril—Vomiting—Methotrexate—bone cancer	0.000518	0.000803	CcSEcCtD
Ramipril—Rash—Methotrexate—bone cancer	0.000514	0.000797	CcSEcCtD
Ramipril—Dermatitis—Methotrexate—bone cancer	0.000514	0.000796	CcSEcCtD
Ramipril—Headache—Methotrexate—bone cancer	0.000511	0.000791	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—bone cancer	0.000507	0.000785	CcSEcCtD
Ramipril—Dizziness—Epirubicin—bone cancer	0.000505	0.000782	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—bone cancer	0.0005	0.000774	CcSEcCtD
Ramipril—Vomiting—Epirubicin—bone cancer	0.000485	0.000752	CcSEcCtD
Ramipril—Nausea—Methotrexate—bone cancer	0.000484	0.00075	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—bone cancer	0.000483	0.000749	CcSEcCtD
Ramipril—Rash—Epirubicin—bone cancer	0.000481	0.000745	CcSEcCtD
Ramipril—Dermatitis—Epirubicin—bone cancer	0.000481	0.000745	CcSEcCtD
Ramipril—Headache—Epirubicin—bone cancer	0.000478	0.000741	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—bone cancer	0.000467	0.000723	CcSEcCtD
Ramipril—Nausea—Epirubicin—bone cancer	0.000453	0.000702	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—bone cancer	0.000449	0.000696	CcSEcCtD
Ramipril—Rash—Doxorubicin—bone cancer	0.000445	0.00069	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—bone cancer	0.000445	0.000689	CcSEcCtD
Ramipril—Headache—Doxorubicin—bone cancer	0.000442	0.000685	CcSEcCtD
Ramipril—Nausea—Doxorubicin—bone cancer	0.000419	0.00065	CcSEcCtD
